Cargando…
Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma
BACKGROUND: Costimulatory molecules play significant roles in mounting anti-tumor immune responses, and antibodies targeting these molecules are recognized as promising adjunctive cancer immunotherapies. Here, we aim to conduct a first full-scale exploration of costimulatory molecules from the B7-CD...
Autores principales: | Zhang, Chaoqi, Zhang, Zhihui, Sun, Nan, Zhang, Zhen, Zhang, Guochao, Wang, Feng, Luo, Yuejun, Che, Yun, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781839/ https://www.ncbi.nlm.nih.gov/pubmed/33457102 http://dx.doi.org/10.1080/2162402X.2020.1824641 |
Ejemplares similares
-
Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020) -
Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer
por: Wu, Peng, et al.
Publicado: (2022) -
A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022) -
Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
por: Zhang, Chaoqi, et al.
Publicado: (2020) -
Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)